Your NON-PROFIT Source for the latest in modern mental health information
"We don't have to suffer anymore."
Your NON-PROFIT Source for the latest in modern mental health information
"We don't have to suffer anymore."
LATEST NEWS ON KETAMINE THERAPY
The Best 4 Treatment Options for Treatment-Resistant Depression
Ketamine for treatment-resistant depression: When and where is it safe?
Ketamine for depression: What it feels like and who it can help FAQs
Recognizing that you’re struggling with depression and getting the courage to ask for help is hard enough as is. But what happens when antidepressants and psychotherapy aren’t helping you to find relief?
Ketamine for depression: What it feels like and who it can help FAQs
Ketamine for treatment-resistant depression: When and where is it safe?
Ketamine for depression: What it feels like and who it can help FAQs
Ketamine is the subject of an enormous amount of interest as a fast-acting treatment for depression and other serious mental health conditions.
Ketamine for treatment-resistant depression: When and where is it safe?
Ketamine for treatment-resistant depression: When and where is it safe?
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Ketamine is approved for hard-to-treat depression, but how safe are outpatient ketamine clinics? Ketamine is an unusual type of psychedelic drug — called a dissociative — that is undergoing a resurgence in popularity.
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Israeli-based psychedelics biotech Clearmind Medicine Inc. and partners have obtained positive results from next-gen psychedelic for the treatment of Major Depressive Disorder.
New Research Shows How Ketamine Acts As “Switch” in the Brain
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes
According to a new study by researchers at Penn Medicine, ketamine, which is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if a switch were turned on.
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes
Israeli Biotech Develops Ketamine Analogue To Treat Major Depression With Promising Results
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes
Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously without a psychotherapeutic component.
LATEST NEWS ON PSYCHEDELIC THERAPY
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
Many are celebrating Australia’s decision to pave the way for these psychedelic therapies, but questions around accessibility remain. In a world first, Australia has announced it will officially recognize MDMA and psilocybin as medicines.
Psychedelics And Mental Health: What Does The Science Say?
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
Psychedelic drugs can induce mind-altering states affecting perception, thought and sensory input. They have historically been known for their recreational use and do not have nationwide legal approval.
Share the Magic mushrooms used to treat depression
MDMA and Psilocybin Are Approved as Medicines for the First Time IN AUSTRALIA
The Use Of Psychedelics In The treatment Of Mental Health Disorders
Researchers found that the magic mushroom compound can be safely administered with appropriate support and used to treat people suffering from types of depression that had been resistant to prior treatments.
The Use Of Psychedelics In The treatment Of Mental Health Disorders
Relieving depression with LSD-like drugs without causing hallucinations
The Use Of Psychedelics In The treatment Of Mental Health Disorders
The use of psychedelic substances was banned by the United States in 1966. Interest in psychedelics has led to many research studies that are looking at the use of psychedelics to treat different mental health disorders.
The Doctor Game: Magic mushrooms moving mainstream
Relieving depression with LSD-like drugs without causing hallucinations
Relieving depression with LSD-like drugs without causing hallucinations
You may have preconceived ideas that magic mushrooms are the party drugs of days past. However, in Canada and other countries, regulations are starting to ease on these prohibited psychedelics.
Relieving depression with LSD-like drugs without causing hallucinations
Relieving depression with LSD-like drugs without causing hallucinations
Relieving depression with LSD-like drugs without causing hallucinations
Psychedelics such as LSD and psilocybin from “magic mushrooms” have been proposed to ease depression. But the hallucination side effect makes these powerful drugs less ideal as therapeutics.